-
1 Comment
Tmc Life Sciences Bhd is currently in a long term downtrend where the price is trading 2.5% below its 200 day moving average.
From a valuation standpoint, the stock is 3.5% cheaper than other stocks from the Other sector with a price to sales ratio of 6.2.
Tmc Life Sciences Bhd's total revenue sank by 7.1% to $49M since the same quarter in the previous year.
Its net income has dropped by 32.1% to $5M since the same quarter in the previous year.
Finally, its free cash flow grew by 0.9% to $-26M since the same quarter in the previous year.
Based on the above factors, Tmc Life Sciences Bhd gets an overall score of 2/5.
| Exchange | KLSE |
|---|---|
| ISIN | MYQ0101OO004 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| CurrencyCode | MYR |
| Market Cap | 793M |
|---|---|
| Dividend Yield | 1.0% |
| Target Price | None |
| Beta | 0.43 |
| PE Ratio | 45.5 |
TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara (THKD), a medical bedded center located in Selangor. Its THKD provides women and children health, cancer, orthopedics, ENT, head and neck laser, gastro, hepato, urology, fertility health services. In addition, the company's reproductive treatment comprises in-vitro fertilisation, preimplantation genetic testing, fertility preservation, laparoscopic surgery, surgical sperm retrieval, and donation programmes; and offers fertility consultancy services; laboratory and embryology; traditional and complementary; pharmacy services and products; and management support and multi-disciplinary tertiary care services. Further, it operates a women's clinic and fertility centers, as well as provides related services; develops, markets, and manages healthcare programs; and operates pharmacy store. Additionally, the company engages in the research and development activities; and property investment activities. TMC Life Sciences Berhad was founded in 1994 and is based in Petaling Jaya, Malaysia. The company is a subsidiary of Sasteria (M) Pte. Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0101.KLSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
